supply of des-abbreviated dapt long -coronary drug eluting stentsdes-abbreviated dapt long -coronary drug eluting stents,srph153048-des-abbreviated dapt long -coronary drug eluting stents wit h (1) platinum chromium alloy (2) coating of bioabsorbable polymer carrier for acti ve drug everolimus shown to be effective in preventing neo-intimal hyperplasia) (3) stent diameter should be from 2.5mm to 4mm. the length of the stent should be fro m 12mm to 48 mm. (4) the strut thickness should be 91 micron or less. (5) stent deliver y system should be monorail (single operator exchange or rapid exchange). (6) ste nt should be compatible with 5fr guiding catheter (7) stent design should be open c ell type. (8) stent should be approved by dcgi. the copy of dcgi approval should be enclosed in the tender bid. (9) the long term efficacy and safety of the stent, the r ates of in-stent restenosis (isr) and in-situ thrombosis (ist) should be documented / published in peer reviewed scientific journals. (10) safety of abbreviated (three mo nth) dual antiplatelet therapy for high bleeding risk patients should be document ed in peer reviewed journals. (11) the manufacturer/supplier should submit proof o f supply of the stent to a major government institute. bis standards for the drug eluting stent are not available. (reference:bis catalogue ). unit:no